BioCryst Pharmaceuticals (United States)
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for BioCryst Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
40%
Total
Publications
224
Total Open
Publications
90
Total
Citations
5.5K
Open Access
Percentage
40%
Total
Publications
224
Total Open
Publications
90
Total
Citations
5.5K
Breakdown
Publisher Open
18%
Both
13%
Other Platform Open
9%
Closed
60%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
24
Hybrid 19%
13
No Guarantees 46%
32
Other Platform Open
Domain 96%
49
Institution 12%
6
Public 10%
5
Other Internet 6%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 49 |
Europe PMC | Domain | 29 |
Semantic Scholar | Public | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 3 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 2 |
Virginia Tech - Virginia Tech Works | Institution | 1 |
Unknown Repository | Other Internet | 1 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 1 |